Detailed Analysis of the Learning Disabilities Treatment Market

Learning Disabilities Treatment Market

Learning Disabilities Treatment Market: Introduction

According to the report, the global learning disabilities treatment market was valued at around US$3 billion in 2018 and is expected to grow at a considerable CAGR during the forecast period. Learning disabilities can be defined as a significant reduction in the ability to understand complex or new information; difficulty learning new skills and reduced ability to cope independently. Various aspects in which people with learning disabilities face problems include learning new things, managing money, learning, reading and writing. Treatment modes available for various forms of learning disabilities include therapies, assistive technology tools, and handwriting training tools. The growth of the global learning disability treatment market can be attributed to the annual increase in the number of students requiring special education.

Get a sample copy of the report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=76947

According to the Department of Education report, in the United States, the number of students aged 3 to 21 receiving special education services increased from 6.6 million in 2015 to 6.7 million in 2017. Among them, more than 34% of students had learning disabilities. , of which more than 20% of them had speech or language disorders.

North America dominated the global learning disabilities treatment market in 2018 and the trend is expected to continue during the forecast period. The high growth of the market in the region can be attributed to the availability of technologically advanced products, changing government regulations, and increasing prevalence of learning disabilities among people. Additionally, growing awareness among people and increasing student enrollment in special education is contributing to the growth of the market in the region.

Government initiatives to place more emphasis on learning disabilities

Governments have taken various initiatives to improve the lives of people with learning disabilities. For example, the Government of England and the NHS focus on reducing health inequalities for people with learning disabilities and have various national programs in place to improve treatment and outcomes. In addition, the NHS long-term plan recently recognized learning disabilities and autism as priority clinical areas. These government initiatives are expected to help raise awareness about learning disabilities, which, in turn, is expected to drive the growth of the market.

Survey before buying @ https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=76947

Dyslexic disease will dominate the global market

In terms of disease type segment, dyslexia is likely to account for a major share of the global learning disability treatment market during the forecast period. The growth of the segment can be attributed to its high prevalence. It is one of the most common forms of learning disabilities in children. The growing awareness among people about learning disabilities is helping in the early diagnosis of the disease, thereby contributing to the growth of the treatment market. Effective treatment modes for dyslexia include academic therapy, audio books, and the use of computer reading and word processing programs.

Read the report preview @ https://www.transparencymarketresearch.com/learning-disabilities-treatment-market.html

Therapy will be the most common treatment

In terms of treatment segment, therapy is likely to account for a major share of the global learning disability treatment market during the forecast period. The growth of the segment can be attributed to the fact that therapy is one of the most common forms of treatment sought after the identification of a disability. The most preferred mode of treatment for learning disabilities includes special education or speech therapy. Therapists help individuals identify and understand their learning disabilities

Learning Disabilities Treatment Market: Major Regions

The global learning disabilities treatment market has been segmented into five major regions: North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America dominated the global learning disability treatment market in 2018. The United States is the major market in the region. Market growth in the region can be attributed to increased awareness of people with learning disabilities, increase in integration of assistive tools such as sound field systems in regular classroom instruction and the increased prevalence of learning disabilities. Asia Pacific learning disabilities treatment market is expected to grow at a high CAGR from 2019 to 2027. Market expansion in the region is expected to be driven by developing countries such as China and India. Market growth in the region can be attributed to increasing prevalence of dyslexia, dysgraphia, and other learning disabilities. Additionally, initiatives by various groups and NGOs to identify and treat these conditions are expected to drive the market in Asia Pacific.

Get a personalized research report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=76947

Focus on product launches by key players to propel the global market

The global learning disability treatment market is fragmented, in terms of the number of players. Key players operating in the global learning disabilities treatment market are Sonova Group, Sensory, Inc., Vocalect Biometric Solutions, LLC, Ginger Software, Inc., Koninklijke Philips NV, Sight and Sound Technology, Oticon, Adaptive Tech Solutions , LLC, Speech Therapy Works, Youth Living Skills and ZYGO-USA.

In February 2020, RAZ Mobility, a mobile assistive technology provider, launched RAZ Memory Cell Phone, for people with developmental disabilities. In 2013, Philips launched LightAide, a wearable device featuring over 224 multi-color LED lights and manageable oversized switch buttons for small hands with limited motor skills.

Ask for references @ https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=76947

Global Learning Disabilities Treatment Market: Segmentation

Learning Disabilities Treatment Market, By Disease Type
Dyslexia
Dysgraphia
Auditory Processing Disorder (APD)
Dyscalculia
Language processing disorder
Others

Learning Disabilities Treatment Market, By Treatment

Assistive Technology Tools (ATT)
Personal listening devices
Sound field systems
Others

Handwriting training tools
Portable word processors
proofreading software
Others

Therapy
occupational therapy
Speech therapy
Others

Others

Learning Disabilities Treatment Market, By End User
Specialized centers
Home Care
Others

About Us

Transparency Market Research, a global market research firm registered in Wilmington, Delaware, USA, provides personalized research and advisory services. The company examines the factors that shape demand dynamics in various markets. Market insights and insights assess opportunities in various segments. Opportunities in segments based on source, application, demographics, sales channel, and end-use are analyzed which will determine the growth of the markets over the next decade.

Our proprietary blend of quantitative forecasting and trend analysis delivers forward-looking insights to thousands of decision makers, made possible by experienced teams of analysts, researchers and consultants. Proprietary data sources and the various tools and techniques we use always reflect the latest trends and information. With a broad research and analytical capability, Transparency Market Research uses rigorous primary and secondary research techniques in all of its trade reports.

For more information on research on leading industries, visit our YouTube channel and click subscribe for future update – https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

Rohit Bhisey
Transparency Market Research Inc.
HEADQUARTERS IN THE CITY CENTER,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
United States – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: [email protected]

This press release was published on openPR.

About Antoine L. Cassell

Check Also

IMU-838 treatment associated with low rate of confirmed disability worsening in relapsing MS

Recently reported interim data from the Phase 2 EMPhASIS trial (NCT03846219) of Immunic’s investigational agent, …